How have AstraZeneca’s recent missteps in reporting COVID-19 vaccine clinical trial results affected the public’s trust, and what’s next on the road to FDA approval? Hear from Emmes Chief Business Officer Lynn Lewis. For more, check out our full interview with Lewis here: https://youtu.be/EnzApF-iz6s.